1. Raynaud’s Secondary to Granulomatosis With Polyangiitis
- Author
-
Shohana Ahmed, Maneesh Mannem, Srikanth Mukkera, Sai Swarupa Vulasala, and Nirmal K. Onteddu
- Subjects
medicine.medical_specialty ,prostacyclins ,medicine.medical_treatment ,sildenafil ,Population ,Ischemia ,Dermatology ,macromolecular substances ,wegener granulomatosis ,Gastroenterology ,Pallor ,Rheumatology ,secondary raynaud ,Internal medicine ,Internal Medicine ,medicine ,education ,Gangrene ,calcium channel blockers ,education.field_of_study ,granulomatosis with polyangiitis ,bosentan ,business.industry ,emerging therapies ,General Engineering ,refractory raynauds ,medicine.disease ,Bosentan ,Sympathectomy ,Amputation ,medicine.symptom ,Granulomatosis with polyangiitis ,business ,raynaud phenomenon ,medicine.drug - Abstract
Raynaud’s phenomenon (RP) is an episodic digital vasospastic condition that is prevalent among 5% of the population. The symptoms range from reversible pallor to ischemia and gangrene. RP can be primary or secondary. We discuss a case of severe RP secondary to granulomatosis with polyangiitis (GPA) that presented with ischemia and gangrene. Studies show that approximately
- Published
- 2021